Literature DB >> 18826467

Cytokines and their role in depression.

Debra Rose Wilson1, Lita Warise.   

Abstract

PURPOSE: This study aims to review the cytokines that mediate the inflammatory process, the interleukins and the interferons, and the interaction of cytokines with serotonin as causative factors in the role of depression.
CONCLUSIONS: Administration of proinflammatory cytokines to treat medical diseases induces depressive symptoms in humans. Patients diagnosed with depression tend to have high levels of cytokine activity and impaired immune response, as well as those patients suffering from inflammatory processes. Proinflammatory cytokines interfere with the body's feedback loop to reduce circulating corticosteroids during the stress response. PRACTICE IMPLICATIONS: Serotonin levels, integrally associated with depression, are lowered when levels of circulating cytokines are high when the precursor tryptophan is reduced.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18826467     DOI: 10.1111/j.1744-6163.2008.00188.x

Source DB:  PubMed          Journal:  Perspect Psychiatr Care        ISSN: 0031-5990            Impact factor:   2.186


  8 in total

1.  Effects of developmental stress and lead (Pb) on corticosterone after chronic and acute stress, brain monoamines, and blood Pb levels in rats.

Authors:  Devon L Graham; Curtis E Grace; Amanda A Braun; Tori L Schaefer; Matthew R Skelton; Peter H Tang; Charles V Vorhees; Michael T Williams
Journal:  Int J Dev Neurosci       Date:  2010-10-08       Impact factor: 2.457

2.  The association between breastfeeding, the stress response, inflammation, and postpartum depression during the postpartum period: Prospective cohort study.

Authors:  Sukhee Ahn; Elizabeth J Corwin
Journal:  Int J Nurs Stud       Date:  2015-06-25       Impact factor: 5.837

Review 3.  Neuroimmune pharmacology of neurodegenerative and mental diseases.

Authors:  Feng-Shiun Shie; Yun-Hsiang Chen; Chia-Hsiang Chen; Ing-Kang Ho
Journal:  J Neuroimmune Pharmacol       Date:  2010-09-07       Impact factor: 4.147

4.  Effects of antidepressant drug therapy with or without physical exercise on inflammatory biomarkers in major depressive disorder: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Beatriz Monteiro Fernandes; Estêvão Scotti-Muzzi; Márcio Gerhardt Soeiro-de-Souza
Journal:  Eur J Clin Pharmacol       Date:  2021-10-27       Impact factor: 2.953

5.  Depressive symptoms and cytokine levels in Serum and Tumor Tissue in patients with an Astrocytoma: a pilot study.

Authors:  Angela R Starkweather; Paula Sherwood; Debra E Lyon; Dana H Bovbjerg; William C Broaddus; R K Elswick; Jamie Sturgill
Journal:  BMC Res Notes       Date:  2014-07-04

6.  Accumulation of natural killer cells in ischemic brain tissues and the chemotactic effect of IP-10.

Authors:  Yao Zhang; Zhongming Gao; Dandan Wang; Tongshuai Zhang; Bo Sun; Lili Mu; Jinghua Wang; Yumei Liu; Qingfei Kong; Xijun Liu; Yue Zhang; Haoqiang Zhang; Jiqing He; Hulun Li; Guangyou Wang
Journal:  J Neuroinflammation       Date:  2014-04-17       Impact factor: 8.322

7.  The possible immunoregulatory and anti-inflammatory effects of selective serotonin reuptake inhibitors in coronavirus disease patients.

Authors:  Mohammed Gaber Mohamed Hamed; Radwa Samir Hagag
Journal:  Med Hypotheses       Date:  2020-07-26       Impact factor: 1.538

8.  Single-nucleotide Polymorphism of CTLA-4 (rs5742909) in Correlation with Schizophrenia Risk Factor.

Authors:  Riyadi Sumirtanurdin; James P Laksono; Haafizah Dania; Fitri N Ramadhani; Dyah A Perwitasari; Rizky Abdulah; Melisa I Barliana
Journal:  J Pharm Bioallied Sci       Date:  2019-12-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.